All
Search
Images
Videos
Maps
News
Copilot
More
Shopping
Flights
Travel
Notebook
Top stories
World Cup Coverage
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Order by
Best match
Most fresh
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
The Lancet
2y
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Copyright: © 2023 Elsevier Ltd. All rights reserved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Removes iceberg lettuce
Diagnosed with blood disorder
China dismisses Trump's claim
Pauses US milk production
Trump threatens Canada tariffs
Court rejects NJ gun ban
1st death in NYC outbreak
Apple reclaims top spot
7.3 quake hits Mexican coast
Family sues NYC utility
Mets’ legend dies at 85
NFL suspends executive
Forest Service staff rescued
Trump's envoy faces protests
Ford recalls 288K+ vehicles
Recalls 735K+ Pillsbury rolls
Landslide in southwest China
Revises imperial succession
To attend World Cup final
'Home Alone 2' star dies
Strike damages Kuwait plant
Speaks on election security
Drops out of governor’s race
UK's new Labour Party leader
Zoox recalls robotaxi software
To sell early access to posts
Match major record with 62s
Multiple wildfires in Spain
Toaster ovens recalled
Game postponed over poor air
DOJ sues Maryland
Allowed on govt. devices
Panthers re-sign Christensen
Consumer sentiment rises
Titans to honor Johnson
Levi Wallace retires from NFL
Hyundai recalls 47K+ vehicles
Feedback
